 |
|
Gene expression findings a step toward better classification and treatment of juvenile arthritis
June 30, 2009Scientists have discovered gene expression differences that could lead to better ways to classify, predict outcome, and treat juvenile idiopathic arthritis (JIA). Eventually such findings could enable doctors to target more aggressive treatment to children at risk of more severe arthritis, while those likely to have milder disease could be spared the stronger treatments that carry a greater risk of side effects. The researchers were supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health.
JIA is an inflammatory and sometimes disabling joint disease that affects an estimated 294,000 children in the United States. At present, making a diagnosis of JIA is imprecise and based largely on the presence of joint inflammation persisting for at least six weeks, for which no other cause can be determined, says Robert A. Colbert, M.D., Ph.D., chief of the NIAMS Pediatric Translational Research Branch. Based on the number of joints involved and other clinical features (fever and rash, for example), doctors classify patients into one of four or five major subtypes of JIA, which helps them predict a patient's most likely outcome and guide appropriate treatments. "But, recent research suggests there is more variability in JIA than the four or five major subtypes we currently recognize," Dr. Colbert says.
In the first of two such NIAMS-supported studies to be published in the July issue of Arthritis & Rheumatism, scientists led by Michael Barnes, Ph.D., of Cincinnati Children's Hospital Medical Center used a large data set to compare a number of children newly diagnosed with one of four major subtypes of JIA - persistent oligoarthritis (affecting four or fewer joints), polyarthritis (affecting five or more joints), systemic arthritis (with fever and rash and inflammation throughout the body) and enthesitis-related arthritis (affecting the junctions between tendons and bones). Using gene expression technology - a method by which scientists can determine the relative levels of expression of thousands of different genes at the same time and compare a pattern from one subject with another - the researchers looked for differences in the children's blood samples that corresponded with the different forms of JIA.
"We analyzed gene expression patterns in blood cells and found that we could indeed distinguish the major subtypes of JIA," says Dr. Colbert, who was a leader of this research program at Cincinnati Children's Hospital Medical Center before coming to NIAMS. "Many of the genes whose expression is altered function in the immune system. This means that not only is there immune activation, but it differs depending on the subtype of JIA that is present."
In the second study, led by Thomas Griffin, M.D., Ph.D., also at Cincinnati Children's Hospital Medical Center, scientists looked more closely at patients from the study with one particular subtype of the disease - polyarticular JIA - to determine if that form was more complicated, or if there were more subgroups than originally thought. They included children with rheumatoid factor (RF) positive JIA, meaning their blood tested positive for an antibody commonly seen in adults with rheumatoid arthritis (RA). Surprisingly, the scientists found patterns of gene expression that indicated at least three subgroups of polyarthritis. There was an older subgroup (average age 11) that included both RF positive and negative children with an inflammatory gene expression signature bearing some resemblance to adult RA. A second older subgroup (RF negative) had less severe arthritis and an anti-inflammatory gene expression signature. A third subgroup was comprised mostly of younger patients (average age 7) who had no clearly defined gene expression signature and did have antinuclear antibodies (ANA). This third subgroup may be more similar to oligoarthritis patients, who frequently have a positive ANA, than to the other subgroups of polyarticular JIA.
Dr. Colbert says the new findings take pediatric rheumatologists a step closer to more precisely classifying JIA, and eventually developing individually tailored treatments that maximize the benefits, while minimizing the risks. "In pediatric rheumatology, we are at the early stages of improving our classification system for JIA. We expect that complementary studies designed to uncover the genetic differences that contribute to susceptibility will confirm the presence of several JIA subtypes, and add important information about what causes this group of diseases," he said. "We look forward to the day when we can use a combination of genetic and gene expression tests in the clinic to help us better diagnose and treat childhood arthritis."
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
"We analyzed gene expression patterns in blood cells and found that we could indeed distinguish the major subtypes of JIA," says Dr. Colbert, who was a leader of this research program at Cincinnati Children's Hospital Medical Center before coming to NIAMS. "Many of the genes whose expression is altered function in the immune system. This means that not only is there immune activation, but it differs depending on the subtype of JIA that is present."
In the second study, led by Thomas Griffin, M.D., Ph.D., also at Cincinnati Children's Hospital Medical Center, scientists looked more closely at patients from the study with one particular subtype of the disease - polyarticular JIA - to determine if that form was more complicated, or if there were more subgroups than originally thought. They included children with rheumatoid factor (RF) positive JIA, meaning their blood tested positive for an antibody commonly seen in adults with rheumatoid arthritis (RA). Surprisingly, the scientists found patterns of gene expression that indicated at least three subgroups of polyarthritis. There was an older subgroup (average age 11) that included both RF positive and negative children with an inflammatory gene expression signature bearing some resemblance to adult RA. A second older subgroup (RF negative) had less severe arthritis and an anti-inflammatory gene expression signature. A third subgroup was comprised mostly of younger patients (average age 7) who had no clearly defined gene expression signature and did have antinuclear antibodies (ANA). This third subgroup may be more similar to oligoarthritis patients, who frequently have a positive ANA, than to the other subgroups of polyarticular JIA.
Dr. Colbert says the new findings take pediatric rheumatologists a step closer to more precisely classifying JIA, and eventually developing individually tailored treatments that maximize the benefits, while minimizing the risks. "In pediatric rheumatology, we are at the early stages of improving our classification system for JIA. We expect that complementary studies designed to uncover the genetic differences that contribute to susceptibility will confirm the presence of several JIA subtypes, and add important information about what causes this group of diseases," he said. "We look forward to the day when we can use a combination of genetic and gene expression tests in the clinic to help us better diagnose and treat childhood arthritis."
NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
Gene Expression Current Events and Gene Expression News RSSNew research into the mechanisms of gene regulation
A team led by Penn State's Ross Hardison, T. Ming Chu Professor of Biochemistry and Molecular Biology, has taken a large step toward unraveling how regulatory proteins control the production of gene products during development and growth.
The Protein Srebp2 Drives Cholesterol Formation in Prion-Infected Neuronal Cells Which May Promote Prion-Dependent Diseases
The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells.
Study reveals why certain drug combinations backfire
Combination drug therapy has become a staple for treating many infections. For instance, doctors treat extensively drug resistant forms of tuberculosis with one drug that breaks down the pathogen's protective barriers and opens the door for another to deliver the deathblow.
Penn Study Provides First Clear Idea of How Rare Bone Disease Progresses
An international team of scientists, led by researchers at the University of Pennsylvania School of Medicine, is taking the first step in developing a treatment for a rare genetic disorder called fibrodysplasia ossificans progressiva (FOP), in which the body's skeletal muscles and soft connective tissue turns to bone, immobilizing patients over a lifetime with a second skeleton.
Why can't chimps speak?
If humans are genetically related to chimps, why did our brains develop the innate ability for language and speech while theirs did not?
Treatment to improve degenerating muscle gains strength
A study appearing in Science Translational Medicine puts scientists one step closer to clinical trials to test a gene delivery strategy to improve muscle mass and function in patients with certain degenerative muscle disorders.
BUSM researchers show dieters can experience neurobiological similarities of drug addicts
Researchers from Boston University School of Medicine (BUSM) have shown that intermittent access to foods rich in fat and sugar induces changes in the brain which are comparable to those observed in drug dependence.
FDA approved leukemia drugs shows promise in ovarian cancer cells
The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found.
Deciphering the regulatory code
Embryonic development is like a well-organised building project, with the embryo's DNA serving as the blueprint from which all construction details are derived.
Experimental agent reduces breast cancer metastasis to bone
Researchers have reduced breast cancer metastasis to bone using an experimental agent to inhibit ROCK, a protein that was found to be over-expressed in metastatic breast cancer.
More Gene Expression Current Events and Gene Expression News Articles
 |
Regulation of Gene Expression by Gary H. Perdew (Author), Jack P. Vanden Heuvel (Author), Jeffrey M. Peters (Author) Regulation of Gene Expression: Molecular Mechanisms presents a comprehensive overview of methods and approaches for characterizing mechanisms of gene regulation. The text is appropriate both as a graduate textbook and a standard laboratory reference and provides the essential groundwork for an advanced understanding of the various mechanisms that may result in altered activity of a specific cell protein. Each of three sections explores mechanisms of gene regulation and expression, and presents methods and protocols for achieving specific experimental goals. Part I focuses on approaches for studying control of mRNA expression and determining target genes for a given transcription copy. Part II outlines the methods for determining how proteins can regulate each other by mediating... |
 |
Gene Expression and Regulation by Jun Ma (Author) This book offers a comprehensive look into the science of gene expression and regulation. Focusing on topics such as actions of nuclear receptors, RNA processing, and DNA methylation and imprinting, "Gene Expression and Regulation" is edited by a leading biologist and includes contributions by experts in the field. Presented in the following five sections, this book covers a full spectrum of topics: The History; The Machinery; The Regulators; The Genome; and Special Topics. The Machinery section covers the transcriptional apparatus and general transcription factors. The Regulators section examines selected gene-specific transcription factors important to regulating gene expression. The Genome section covers issues relevant to the behavior of the genome in relation to gene regulation. The... |
 |
The Psychobiology of Gene Expression by Ernest L. Rossi (Author) Outlines the relationship between genes and human experience. The understandings of gene expression emerging from the Human Genome Project are setting the stage for a profound expansion of our understanding of life. We are just now beginning to learn how the brain, body, and genes interact in everyday life. Here, Ernest Rossi introduces the new science of psychosocial genomics and explores how it will profoundly change our understanding of the pathways of communication among mind, body, and spirit. |
 |
Gene Regulation (BIOS Advanced Text) by David Latchman (Author) Gene regulation is an essential process in the development and maintenance of a healthy body, and as such is a central focus in both basic science and medical research. Gene Regulation, Fifth Edition, provides the student with a clear, up-to-date description of gene regulation in eukaryotes, distilling the vast and complex primary literature into a concise overview. For this fifth edition, in addition to extensive updating of existing material, sections on large-scale methodologies have been expanded, and a new section included on regulation by small interfering RNAs. More detail has been added on the role of multi-protein complexes in transcriptional activation and the discussion of the regulation of transcription factor activity by specific modifications to include acetylation... |
 |
Gene Expression by Seed Media Group A scientific blog interested in evolutionary biology, with a particular focus on evolutionary, population and quantitative genetics. Kindle blogs are fully downloaded onto your Kindle so you can read them even when you're not wirelessly connected. And unlike RSS readers which often only provide headlines, blogs on Kindle contain full text content and images, and are updated wirelessly throughout the day. |
 |
Microarray: Gene Expression Analysis by Virendra Gomase (Author) Microarray is an authoritative work whose goal is to illuminate the crucial role of research methodology in the life sciences. Microarray book will adopt an inclusive editorial approach, encompassing fundamental and blue-sky science and have more immediate medical or commercial applications. The scope and structure of the work will reflect the multidimensional character of drug design, focusing in particular on the fundamental science of biological structures and systems, the use of chemical and biological techniques to elucidate that science, and the applications of this knowledge in areas as diverse as drug discovery. This book contains practical examples, theoretical approaches, a large number of examples and references. Complete theory related to drug design has been covered for the... |
|
Techniques in Genetic Engineering 5: Expression of Cloned Genes [VHS] Starring: Tim Harris | |
 |
Celestial Plea by Gene Newton |
 |
Cap-analysis Gene Expression (Cage): Genome-scale Promoter Identification and Association With Expression Profile and Regulatory Networks by Piero Carninci (Author) The output of eukaryotic genomes is much more complex than expected. Genes produce different variants of RNAs from multiple promoters. One of the ultimate targets of biological analysis is to establish a relationship between the messenger RNAs that are transcribed from the genome and the genomic regions that control their expression - the promoters - in order to decipher the networks that regulate gene expression and the transcription factors that act as master regulators of transcriptional control. Novel technologies have recently appeared that allow deciphering of transcriptional network, based on the identification of the starting site of gene transcription, with the simultaneous measurement of expression level and identification of the promoter elements.These tagging technologies... |
 |
GENE KELLY SINGING IN THE RAIN 8X10 PHOTO Beautiful photograph. Printed on photographic paper from an actual negative. Add to your collection. Will look great on a media room wall. Please check out the rest of our collection. Will be adding more. |
| © 2009 BrightSurf.com |